Neutrophils treated with NADPH oxidase inhibitors or cells from CGD patients show impaired NET formation in response to phorbol-12-myristate-13-acetate (PMA) or S. aureus [56], and CGD gene therapy restored NET formation [59], suggesting that ROS are indispensable for NET formation. The gene discussed is FMO5; the disease is chronic granulomatous disease.